ElevAAte and the push for East Asian American leaders in biopharma

on

Title

ElevAAte:
Advancing East Asian American Leadership in Biopharma

Keywords

  • ElevAAte
  • East Asian American leadership
  • Biopharma C-suite diversity
  • Nonprofit organizations
  • Representation in biotech
  • Career advancement
  • Mentorship in life sciences
  • Asian American executives

Key Facts

- Underrepresentation at the Top:
East Asian Americans are well represented in entry-level and middle management roles in U.S. biopharma, but dramatically underrepresented in C-suite and CEO positions, particularly at large biopharma and Big Pharma companies. As of January 2025, only 2.75% of Big Pharma C-suite executives were East Asian American, with none having ever served as CEO of a major U.S.-based Big Pharma company143.

- ElevAAte’s Mission:
The nonprofit ElevAAte was launched in early 2025 to address this leadership gap. It aims to cultivate the next generation of East Asian American leaders in biopharma through awareness, leadership development, and community building234.

- Founding Team:
ElevAAte’s founding directors include high-profile investors and executives such as Lorence Kim (former CFO of Moderna), Bong Koh, Chen Yu, June Lee, Ken Song, Angie You, and investment banker Matt Kim. These leaders are committed to providing mentorship, networking, and skills development specifically for East Asian American professionals in life sciences23.

- Why the Gap Exists:
Despite significant contributions and visibility in technical and operational roles, East Asian Americans face systemic barriers to advancement into the highest ranks of leadership. This includes a lack of mentors from similar backgrounds and cultural factors that may discourage self-promotion or advocacy for top positions13.

- Activities and Approach:
ElevAAte offers networking events, leadership training (virtual and in-person), and platforms to highlight successful East Asian role models. These initiatives are designed to help professionals find their voice, build confidence, and prepare for leadership roles24.

- Industry Impact:
While many East Asian Americans lead smaller biotechs, their numbers drop sharply in executive ranks at major companies, where the most influential decisions and profits occur. ElevAAte aims to bridge this gap, offering community and guidance where it is most needed13.

- Advice and Inspiration:
ElevAAte’s leaders, such as Angie You and Ken Song, actively mentor rising professionals, share actionable career advice, and emphasize collective advocacy to empower the next generation234.

In summary, ElevAAte is a response to persistent underrepresentation of East Asian Americans in top biopharma leadership, providing tailored support, mentorship, and advocacy to drive lasting change in the industry2341.

Sources:

1. https://www.elevaatebiotech.org/pharma-leadership-East-Asian-American/

2. https://www.biocentury.com/article/654632/elevaate-cultivating-the-next-generation-of-east-asian-american-leaders

3. https://www.fiercepharma.com/pharma/aapi-series-elevaate

4. https://www.fiercebiotech.com/biotech/though-prevalent-lab-and-middle-management-east-asian-americans-are-underrepresented